Related Experiment Video
Updated: Sep 24, 2025
08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
16.0K
Evolving Treatment Approaches to Mucosal Melanoma
Shuai Zhang1, Jiaran Zhang1, Jun Guo1
1Department of Melanoma and Sarcoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education, Beijing), Peking University Cancer Hospital and Institute, No. 52 Fucheng Road, Haidian District, Beijing, 100142, China.
Current Oncology Reports
|May 5, 2022
Summary
Mucosal melanoma, distinct from cutaneous melanoma, shows aggressive behavior and unique molecular features. Recent advances offer promising targeted and combination therapies for this rare cancer.
Area of Science:
- Oncology
- Dermatology
- Cancer Research
Background:
- Mucosal melanoma differs from cutaneous melanoma in epidemiology, clinical presentation, and molecular characteristics.
- It exhibits more aggressive biological behavior and a distinct tumor microenvironment.
- Systemic therapies have historically shown less efficacy compared to cutaneous melanoma.
Purpose of the Study:
- To review the unique features of mucosal melanoma.
- To discuss the evolution of therapeutic options in neoadjuvant, adjuvant, and palliative settings.
- To highlight recent advancements in treating mucosal melanoma.
Main Methods:
- Literature review of recent studies on mucosal melanoma.
- Analysis of epidemiological, clinical, and molecular data.
- Evaluation of current and emerging therapeutic strategies.
Main Results:
- Mucosal melanoma is characterized by lower mutational burden and unique driver mutations.
- Emerging therapies include targeted agents and combination treatments, particularly with anti-PD-1/PD-L1 antibodies.
- Anti-angiogenic and PD-1/PD-L1 combinations show promise in early trials.
Conclusions:
- Understanding the unique biology of mucosal melanoma is crucial for improving patient outcomes.
- Recent therapeutic advancements offer new hope for patients with this distinct melanoma subtype.
- Further research into targeted therapies and combination strategies is warranted.
Related Concept Videos
01:30Skin Cancer
4.7K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.7K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
01:27Tumor Immunotherapy
682
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
682
02:57Targeted Cancer Therapies
7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.9K
01:30Cancer Vaccines
528
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
528
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K